• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗药物对大鼠前列腺肿瘤克隆形成细胞的直接作用。

Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cells.

作者信息

Geldof A A, Rao B R, de Voogt H J

出版信息

Anticancer Res. 1986 Jul-Aug;6(4):837-40.

PMID:3752961
Abstract

A semisolid agar assay to determine the number of colony forming cells in monodispersed cell suspensions of the rat prostate hormone independent tumor variant R3327-Mat Lu was established. Using this technique the effects of several chemotherapeutic agents upon the clonogenic potential of the tumor cells were investigated. Adriamycin and cisplatinum proved to be effective in reducing the number of colonies formed, in a dose dependent manner. The combined, sequential incubation with adriamycin and cisplatinum did not have a synergistic effect. Cyclophosphamide. Hydroxyurea, 5-fluorouracil and methotrexate were not effective in the reduction of the number of colonies in vitro at concentrations as high as 500 micrograms/ml. Interestingly treatment with these agents increased the number of colonies formed, compared to control.

摘要

建立了一种半固体琼脂试验,用于测定大鼠前列腺激素非依赖性肿瘤变体R3327-Mat Lu单分散细胞悬液中集落形成细胞的数量。使用该技术研究了几种化疗药物对肿瘤细胞克隆形成潜力的影响。阿霉素和顺铂被证明能以剂量依赖的方式有效减少形成的集落数量。阿霉素和顺铂联合、序贯孵育没有协同作用。环磷酰胺、羟基脲、5-氟尿嘧啶和甲氨蝶呤在浓度高达500微克/毫升时,在体外减少集落数量方面无效。有趣的是,与对照相比,用这些药物处理增加了形成的集落数量。

相似文献

1
Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cells.化疗药物对大鼠前列腺肿瘤克隆形成细胞的直接作用。
Anticancer Res. 1986 Jul-Aug;6(4):837-40.
2
[In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
Bull Cancer. 1984;71(4):287-91.
3
A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.一种用于评估体外克隆形成试验预测体内肿瘤反应能力的小鼠模型。
Cancer Res. 1988 Oct 1;48(19):5447-54.
4
[Human tumor clonogenic assay in human breast cancer].[人乳腺癌的人肿瘤克隆形成试验]
Gan To Kagaku Ryoho. 1985 Aug;12(8):1566-72.
5
[Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents].[人腹水型卵巢癌细胞克隆形成细胞对抗肿瘤药物的敏感性]
Eksp Onkol. 1987;9(4):47-50.
6
[Clinical experiences with in vitro testing of chemotherapeutic agents].[化疗药物的体外测试临床经验]
HNO. 1985 Aug;33(8):374-6.
7
[In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
Gan To Kagaku Ryoho. 1985 Aug;12(8):1582-7.
8
Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.核苷类似物BCH-4556对前列腺癌体外及体内生长和转移的影响。
Cancer Res. 1998 Aug 1;58(15):3461-5.
9
[An in vitro chemosensitivity study using human tumor clonogenic assay in urologic malignancies].
Hinyokika Kiyo. 1986 Dec;32(12):1959-66.
10
[Comparative study of chemosensitivity tests of human urogenital tumors between a clonogenic assay and a novel dye exclusion test].
Gan To Kagaku Ryoho. 1985 Jun;12(6):1294-300.

引用本文的文献

1
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.[18F]氟甲基胆碱作为前列腺癌细胞化疗反应的读出指标
Mol Imaging Biol. 2015 Jun;17(3):319-27. doi: 10.1007/s11307-014-0803-7.
2
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cells.神经生长因子刺激DU145人前列腺癌细胞的体外侵袭能力。
J Cancer Res Clin Oncol. 1997;123(2):107-12. doi: 10.1007/BF01269888.
3
Nerve-growth-factor-dependent neurite outgrowth assay; a research model for chemotherapy-induced neuropathy.
神经生长因子依赖性神经突生长测定;化疗诱导的神经病变的研究模型。
J Cancer Res Clin Oncol. 1995;121(11):657-60. doi: 10.1007/BF01218523.
4
Development of an in vivo clonogenic cell assay for rat prostate metastatic tumor--R3327-MatLyLu.大鼠前列腺转移性肿瘤——R3327-MatLyLu体内克隆形成细胞试验的开发
Urol Res. 1987;15(3):139-44. doi: 10.1007/BF00254425.
5
Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapy.考虑使用5α-还原酶抑制剂17β-N,N-二乙基氨基甲酰基-4-甲基-4-氮杂-5α-雄甾烷-3-酮(4MA)进行前列腺癌治疗。
J Cancer Res Clin Oncol. 1992;118(1):50-5. doi: 10.1007/BF01192311.